Nektar Therapeutics (NKTR) EPS (Basic) (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly EPS (Basic) came in at -$1.74 in Q1 2026, up 47.15% year-on-year from -$1.19 in Q1 2025, and down 7525.04% quarter-over-quarter from -$0.02 in Q4 2025.
Nektar Therapeutics (NKTR) EPS (Basic) (2010 - 2026) Analysis & Trends
Nektar Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$1.74 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 47.15% year-over-year to -$1.74 in Q1 2026; TTM through Mar 2026 was -$4.76, a 35.51% increase from a year earlier, with the FY2025 full-year figure at -$7.17, down 4.43% from the prior year.
- EPS (Basic) slipped to -$1.74 in Q1 2026 per NKTR's latest filing, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.34 in Q4 2024 and bottomed at -$12.77 in Q2 2022.
- The 5-year median for EPS (Basic) is -$3.3 (2025), against an average of -$3.63.
- Across the five-year window, EPS (Basic) sank 305.44% in 2023 and soared 170.38% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $1.62 in 2022, then sank by 305.44% to -$3.32 in 2023, then surged by 170.38% to $2.34 in 2024, then slumped by 100.98% to -$0.02 in 2025, then sank by 7525.04% to -$1.74 in 2026.
- Per Business Quant, the three latest NKTR EPS (Basic) figures stand at -$1.74 (Q1 2026), -$0.02 (Q4 2025), and -$1.85 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | -1.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.74 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -1.85 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.30 |
| Dec 31, 2024 | 2.34 |
| Sep 30, 2024 | -2.66 |
| Jun 30, 2024 | -3.76 |
| Mar 31, 2024 | -2.83 |
| Dec 31, 2023 | -3.32 |
| Sep 30, 2023 | -3.61 |
| Jun 30, 2023 | -4.04 |
| Mar 31, 2023 | -10.88 |
| Dec 31, 2022 | 1.62 |
| Sep 30, 2022 | -4.72 |
| Jun 30, 2022 | -12.77 |
| Mar 31, 2022 | -7.30 |
| Dec 31, 2021 | 31.00 |
| Sep 30, 2021 | -10.57 |
| Jun 30, 2021 | -10.30 |